Patents by Inventor Julio Reinecke

Julio Reinecke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090047242
    Abstract: The present invention relates to methods for the production of conditioned blood compositions which comprise induced factors, and to conditioned blood compositions preparable by the method and to the use thereof for the treatment or prevention of a disorder of the human or animal body.
    Type: Application
    Filed: February 2, 2007
    Publication date: February 19, 2009
    Inventors: Julio Reinecke, Peter Wehling
  • Patent number: 7465293
    Abstract: A syringe for inducing therapeutically-effective proteins includes a syringe and an inner structure having an inductor disposed thereon for encouraging development of a desired protein.
    Type: Grant
    Filed: March 3, 2003
    Date of Patent: December 16, 2008
    Assignee: Orthogen Gentechnologie GmbH
    Inventors: Julio Reinecke, Hans Meijer, Peter Wehling
  • Publication number: 20080286379
    Abstract: Method and means for obtaining thrombocyte-rich plasma (platelet-rich plasma, PRP) from whole blood which specifically has a high content of specifically activated thrombocytes and which is particularly easy to coagulate.
    Type: Application
    Filed: July 29, 2005
    Publication date: November 20, 2008
    Inventors: Peter Wehling, Julio Reinecke
  • Publication number: 20040156823
    Abstract: A syringe for inducing therapeutically-effective proteins includes a syringe and an inner structure having an inductor disposed thereon for encouraging development of a desired protein.
    Type: Application
    Filed: March 3, 2003
    Publication date: August 12, 2004
    Inventors: Julio Reinecke, Hans Meijer, Peter Wehling
  • Patent number: 6759188
    Abstract: The present invention relates to a method for producing a prophylactically or therapeutically active protein, the syringe being filled with a body fluid and incubated, and the prophylactically or therapeutically active protein subsequently being formed in the body fluid.
    Type: Grant
    Filed: December 31, 2002
    Date of Patent: July 6, 2004
    Assignee: Orthogen AG
    Inventors: Julio Reinecke, Hans Meijer, Peter Wehling
  • Patent number: 6713246
    Abstract: The present invention relates to a method for producing interleukin-1 receptor antagonists, a prophylatically or therapeutically effective protein. A syringe is filled with a body fluid and incubated. The prophylatically or therapeutically effective protein is then produced in the body fluid.
    Type: Grant
    Filed: August 1, 2001
    Date of Patent: March 30, 2004
    Assignee: Orthogen AG
    Inventors: Julio Reinecke, Hans Meijer, Peter Wehling
  • Publication number: 20030138910
    Abstract: The present invention relates to a method for producing a prophylactically or therapeutically active protein, the syringe being filled with a body fluid and incubated, and the prophylactically or therapeutically active protein subsequently being formed in the body fluid.
    Type: Application
    Filed: December 31, 2002
    Publication date: July 24, 2003
    Inventors: Julio Reinecke, Hans Meijer, Peter Wehling